activationacuteadultadultsagingallogeneicamlamyloidosisanemiaantiantibodiesantibodyantigenaplasticasciminibassessmentassociatedazacitidinebispecificbleedingbonecancercd19celcellcellschemotherapychildrenchronicclinicalcllclonalcmlcnscombinationcovidcytokinedaratumumabdiagnoseddiagnosisdiffusediseasedisordersdlbcldonordosedrivesdualearlyeffectsfactorfailurefixedflt3follicularfunctiongenegeneticgenomicgermlinegvhdhcthematologichematopoiesishematopoietichemophagocytichemophiliahighhlhhodgkinhomeostasishschscthumanibrutinibimmuneimmunityimpactinducedinfectioninflammationinhibitioninhibitorinhibitorsinsightsironitpittpkinaselargelenalidomideleukemialinelonglosslowlymphoblasticlymphohistiocytosislymphomalymphomasmacrophagemaintenancemalignanciesmalignancymantlemarrowmdsmechanismsmicroenvironmentmmmodelmolecularmonoclonalmrdmultiplemutantmutatedmutationsmyeloidmyelomamyeloproliferativenegativeneoplasmsneutrophilnewlynknovelnpm1obinutuzumabolderoutcomesoverloadpatientspediatricpembrolizumabphplateletplateletspluspositivepostpredictionpreventionprognosticpromotesprophylaxisrapidrealreceptorrefractoryrelapserelapsedrelatedresearchresistanceresponsereviewriskrituximabroleruxolitinibscdseasonseriesseveresicklesignalingspecificstemstrokesurvivalsyndrometargetingtermthalassemiatherapeutictherapiestherapythrombocytopeniathrombosisthrombotictp53transplanttransplantationtreattreatedtreatingtreatmenttrialttpusingvariantsvenetoclaxvenousversusvexasvtevwfwillebrandworld